| AT101-loaded cubosomes as an alternative for improved glioblastoma therapy DK Flak, V Adamski, G Nowaczyk, K Szutkowski, M Synowitz, S Jurga, ... International journal of nanomedicine, 7415-7431, 2020 | 56 | 2020 |
| The intramembrane protease SPPL 2c promotes male germ cell development by cleaving phospholamban J Niemeyer, T Mentrup, R Heidasch, SA Müller, U Biswas, R Meyer, ... EMBO reports 20 (3), e46449, 2019 | 36 | 2019 |
| Dormant glioblastoma cells acquire stem cell characteristics and are differentially affected by Temozolomide and AT101 treatment V Adamski, A Hempelmann, C Flüh, R Lucius, M Synowitz, K Hattermann, ... Oncotarget 8 (64), 108064-108078, 2017 | 36 | 2017 |
| NKG2D ligands in glioma stem-like cells: expression in situ and in vitro C Flüh, G Chitadze, V Adamski, K Hattermann, M Synowitz, D Kabelitz, ... Histochemistry and cell biology 149, 219-233, 2018 | 33 | 2018 |
| Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1 V Adamski, K Hattermann, C Kubelt, G Cohrs, R Lucius, M Synowitz, ... Oncogene 39 (22), 4421-4435, 2020 | 26 | 2020 |
| Effects of sequentially applied single and combined temozolomide, hydroxychloroquine and AT101 treatment in a long-term stimulation glioblastoma in vitro model V Adamski, C Schmitt, F Ceynowa, R Adelung, R Lucius, M Synowitz, ... Journal of cancer research and clinical oncology 144, 1475-1485, 2018 | 20 | 2018 |
| Isolation and characterization of fast-migrating human glioma cells in the progression of malignant gliomas V Adamski, AD Schmitt, C Flüh, M Synowitz, K Hattermann, J Held-Feindt Oncology Research 25 (3), 341, 2017 | 15 | 2017 |
| Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells M Mehner, C Kubelt, V Adamski, C Schmitt, M Synowitz, J Held-Feindt Journal of Cancer Research and Clinical Oncology 146, 117-126, 2020 | 14 | 2020 |
| Macroscopic silicone microchannel matrix for tailored drug release and localized glioblastoma therapy F Rasch, C Schmitt, LM Saure, R Meyer, V Adamski, D Dengiz, ... ACS Biomaterials Science & Engineering 6 (6), 3388-3397, 2020 | 13 | 2020 |
| The chemokine receptor CXCR6 evokes reverse signaling via the transmembrane chemokine CXCL16 V Adamski, R Mentlein, R Lucius, M Synowitz, J Held-Feindt, ... International journal of molecular sciences 18 (7), 1468, 2017 | 12 | 2017 |
| Establishment of a glioblastoma in vitro (in) complete resection dual co-culture model suitable for drug testing C Schmitt, V Adamski, F Rasch, R Adelung, R Lucius, M Synowitz, ... Annals of Anatomy-Anatomischer Anzeiger 228, 151440, 2020 | 11 | 2020 |
| Dormancy and NKG2D system in brain metastases: Analysis of immunogenicity C Flüh, V Mafael, V Adamski, M Synowitz, J Held‑Feindt International Journal of Molecular Medicine 45 (2), 298-314, 2020 | 9 | 2020 |
| Analysis of chemotherapeutic-induced tumor dormancy in Glioblastoma Multiforme and alternative therapy approaches V Adamski | | 2019 |
| P02. 02 NKG2D ligand expression and tumor dormancy in brain metastases C Flueh, V Mafael, V Adamski, K Hattermann, M Synowitz, J Held-Feindt Neuro-Oncology 20 (Suppl 3), iii272, 2018 | | 2018 |
| Dormancy and NKG2D system in brain metastases: Analysis of immunogenicity F cHARLOTTE, V MAFAEL, V AdAMSKI, M SYNOWITZ, J HELd-FEINdT | | |
Kirsten HattermannKiel University, Institute of AnatomyE-mail megerősítve itt: anat.uni-kiel.de
